AWS
CVS icon

Atria Wealth Solutions’s CVS Health CVS Stock Holding History

Atria Wealth Solutions’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.75M Sell
25,384
-29,858
-54% -$1.96M 0.04% 459
2025
Q1 		$3.74M Sell
55,242
-6,918
-11% -$414K 0.05% 426
2024
Q4 		$2.79M Buy
62,160
+23,849
+62% +$1.34M 0.03% 528
2024
Q3 		$2.41M Sell
38,311
-14,425
-27% -$842K 0.03% 565
2024
Q2 		$3.11M Sell
52,736
-13,442
-20% -$841K 0.03% 478
2024
Q1 		$5.28M Sell
66,178
-5,177
-7% -$395K 0.06% 325
2023
Q4 		$5.63M Sell
71,355
-2,960
-4% -$211K 0.07% 279
2023
Q3 		$5.19M Buy
74,315
+176
+0.2% +$12.5K 0.07% 281
2023
Q2 		$5.13M Sell
74,139
-3,036
-4% -$216K 0.07% 280
2023
Q1 		$5.73M Sell
77,175
-3,955
-5% -$332K 0.08% 236
2022
Q4 		$7.56M Sell
81,130
-1,665
-2% -$161K 0.12% 181
2022
Q3 		$7.9M Buy
82,795
+48,142
+139% +$4.77M 0.14% 155
2022
Q2 		$3.21M Sell
34,653
-30,000
-46% -$2.93M 0.06% 328
2022
Q1 		$6.54M Buy
+64,653
New +$6.79M 0.11% 202

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Atria Wealth Solutions's CVS Position: Q2 2025 in Review

Atria Wealth Solutions reduced its CVS Health (CVS) stake by 54% in Q2 2025, selling an estimated $1.96M and leaving 25,384 shares worth $1.75M. The position accounts for 0.04% of the portfolio, ranked #459.

Atria Wealth Solutions first reported a position in CVS in Q1 2022 and has held it in 14 quarters since. The position peaked at $7.9M in Q3 2022. 1,759 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Atria Wealth Solutions held 25,384 shares of CVS Health worth $1.75M as of Q2 2025.
  • Atria Wealth Solutions sold 29,858 CVS Health shares in Q2 2025, an estimated $1.96M.
  • CVS Health made up 0.04% of Atria Wealth Solutions's portfolio in Q2 2025, its #459 holding.
  • Atria Wealth Solutions first reported a position in CVS Health in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's CVS Health position peaked at $7.9M in Q3 2022.
  • 1,759 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.